We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+0.69%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.44B
AUM Growth
-$465M
Cap. Flow
-$442M
Cap. Flow %
-30.7%
Top 10 Hldgs %
11.9%
Holding
1,595
New
313
Increased
337
Reduced
470
Closed
413

Sector Composition

Rank Sector Weight
1 Technology 17.01%
2 Healthcare 10.93%
3 Consumer Discretionary 9.87%
4 Industrials 9.31%
5 Financials 6.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HIBB
351
DELISTED
Hibbett, Inc. Common Stock
HIBB
$867K 0.06%
9,945
+5,006
+101% +$414K
CIEN icon
352
Ciena
CIEN
$58.4B
$864K 0.06%
17,941
-20,739
-54% -$984K
RDY icon
353
Dr. Reddy's Laboratories
RDY
$10.2B
$861K 0.06%
56,500
-18,500
-25% -$265K
STNG icon
354
Scorpio Tankers
STNG
$3.81B
$861K 0.06%
10,586
-21,999
-68% -$1.68M
BCS icon
355
Barclays
BCS
$94.1B
$857K 0.06%
80,000
GFR icon
356
Greenfire Resources
GFR
$771M
$856K 0.06%
126,776
+28,201
+29% +$171K
QCOM icon
357
Qualcomm
QCOM
$176B
$853K 0.06%
4,281
-771
-15% -$146K
INSM icon
358
Insmed
INSM
$28.6B
$851K 0.06%
12,700
-4,604
-27% -$179K
EDR
359
PUT
DELISTED
Endeavor Group Holdings, Inc.
EDR
$841K 0.06%
31,100
-4,500
-13% -$120K
XOP icon
360
PUT
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.43B
$829K 0.06%
+5,700
New +$862K
AGI icon
361
Alamos Gold
AGI
$13.9B
$828K 0.06%
52,794
-12,106
-19% -$190K
ECPG icon
362
Encore Capital Group
ECPG
$2.13B
$799K 0.06%
19,146
+2,572
+16% +$111K
PPLI
363
People Inc
PPLI
$3.1B
$795K 0.06%
+20,684
New +$855K
EOG icon
364
EOG Resources
EOG
$70.7B
$792K 0.06%
6,296
+1,854
+42% +$238K
BWXT icon
365
BWX Technologies
BWXT
$15.6B
$792K 0.06%
8,333
-8,378
-50% -$777K
LOGI icon
366
Logitech
LOGI
$15.2B
$789K 0.05%
8,146
+3,481
+75% +$313K
M icon
367
Macy's
M
$6.68B
$785K 0.05%
40,871
+5,003
+14% +$95.5K
LKQ icon
368
LKQ Corp
LKQ
$6.29B
$781K 0.05%
+18,767
New +$839K
BAH icon
369
Booz Allen Hamilton
BAH
$9.15B
$779K 0.05%
5,064
-8,028
-61% -$1.2M
CRWD icon
370
CrowdStrike
CRWD
$218B
$779K 0.05%
8,128
-16,540
-67% -$1.38M
WSR
371
DELISTED
Whitestone REIT
WSR
$777K 0.05%
58,414
+4,936
+9% +$60.7K
OPY icon
372
Oppenheimer Holdings
OPY
$1.2B
$767K 0.05%
16,000
CMC icon
373
Commercial Metals
CMC
$8.31B
$765K 0.05%
13,913
-14,510
-51% -$801K
AAMI
374
Acadian Asset Management
AAMI
$3.19B
$764K 0.05%
34,450
+1,477
+4% +$33.3K
IPG
375
DELISTED
Interpublic Group of Companies
IPG
$759K 0.05%
+26,105
New +$804K

Similar funds

Prelude Capital Management's Q2 2024 Portfolio in Review

As of Q2 2024, Prelude Capital Management held 1,595 positions worth $1.44B, down 24% from $1.91B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Prelude Capital Management withdrew a net $442M in Q2 2024, closing 413 positions and reducing 470 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $16.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Prelude Capital Management opened a new position in Constellation Energy worth $6.37M.

  • Prelude Capital Management's largest Q2 2024 buy was Constellation Energy: 31,786 shares worth $6.37M.
  • Prelude Capital Management added most to Cerevel Therapeutics Holdings, Inc. Common Stock in Q2 2024, an estimated $6.05M increase.
  • Prelude Capital Management's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $13.1M.
  • Prelude Capital Management fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $16.5M.
  • Prelude Capital Management's ten largest holdings make up 12% of its $1.44B portfolio in Q2 2024.
  • Prelude Capital Management opened 313 new positions and closed 413 in Q2 2024.
  • Prelude Capital Management's portfolio value fell 24% quarter-over-quarter to $1.44B.

Based on Prelude Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.